Hauser
Executive Summary
Bristol-Myers Squibb will not extend Taxol (paclitaxel) supply agreement beyond Aug. 14, 1994 termination of current contract. "Production and delivery schedules for bulk paclitaxel through August 1994 remain unchanged," Hauser says. "Hauser and Bristol continue to discuss a number of near-term and long-term Taxol- related projects as well as other projects," the supplier notes.